ArticleJournal for immunotherapy of cancer2022

Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.

Qi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.